Delivery Order SPE2DR25D1017-SPE2DR26F8ZLL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $16,775.89. This firm fixed-price delivery order, with an ultimate completion date of November 12, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. The contract is performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,496.42. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by October 24, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $16,991.63 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 15, 2025. The delivery order was issued on September 12, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg with a ceiling value of $7,417.34 under a firm fixed price contract type. The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $46,287.17. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 3, 2025. AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $9,461.61. This firm fixed-price delivery order, which is not set-aside, is expected to be completed by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $73,131.51 to AmerisourceBergen Drug Corp for supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The award, issued on September 23, 2025, with completion targeted for September 24, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Otezla 30 mg tablets in a 60-count quantity. This competitively awarded, non-set-aside contract has a ceiling value of $23,776.76 and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The firm fixed price delivery order represents a single-transaction procurement from...
- The Defense Logistics Agency awarded a delivery order valued at $11,155.49 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive set-aside contract. The award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F8ZLLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $11,367.67. The award was made on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling Defense Logistics Agency pharmaceutical requirements across multiple therapeutic domains, including specialty medications and dermatological treatments such as Otezla.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 11/12/25 |